OncoImmunology
Volume 2, 2013 - Issue 5
Open access
722
Views
32
CrossRef citations to date
0
Altmetric
Original Research
The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
Aaron S. Mansfield Department of Oncology; Mayo Clinic; Rochester, MN USA; Department of Internal Medicine; Division of Hematology; Mayo Clinic; Rochester, MN USACorrespondence[email protected]
, Wendy K. Nevala Department of Immunology; Mayo Clinic; Rochester, MN USA
, Elizabeth Ann T. Lieser Mayo Graduate School; Mayo Clinic; Rochester, MN USA
, Alexey A. Leontovich Health Sciences Research; Mayo Clinic; Rochester, MN USA
& Svetomir N Markovic Department of Oncology; Mayo Clinic; Rochester, MN USA; Department of Internal Medicine; Division of Hematology; Mayo Clinic; Rochester, MN USA; Department of Immunology; Mayo Clinic; Rochester, MN USA
Article: e24436
|
Received 14 Feb 2013, Accepted 25 Mar 2013, Published online: 01 May 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.